Related Experiment Video
Updated: Jul 24, 2026

Direct Intrabronchial Administration to Improve the Selective Agent Deposition Within the Mouse Lung
Published on: May 20, 2019
Beta-adrenergic agonists increase lung liquid clearance in anesthetized sheep
Beta-adrenergic agonists, like terbutaline and epinephrine, enhance lung liquid clearance in adult sheep. This effect is mediated by beta receptors and involves sodium transport, not changes in blood flow.
Area of Science:
- Pulmonary Physiology
- Pharmacology
Background:
- Lung liquid balance is crucial for respiratory function.
- Understanding mechanisms that enhance lung liquid clearance is important for treating pulmonary edema.
Purpose of the Study:
- To investigate if beta-adrenergic agonists increase lung liquid clearance in adult sheep.
- To determine if this effect is mediated by beta receptors and identify the underlying mechanism.
Main Methods:
- Instillation of autologous serum with or without beta-adrenergic agonists (terbutaline, epinephrine) into sheep lungs.
- Administration of beta-blockers (propranolol) and sodium channel blockers (amiloride) to assess mediation.
- Monitoring of lung liquid clearance, pulmonary hemodynamics, and lymph flow.
Main Results:
- Terbutaline and epinephrine significantly increased lung liquid clearance.
- The increase was inhibited by propranolol and amiloride.
- No significant changes were observed in pulmonary hemodynamics, blood flow, or lymph flow.
Conclusions:
- Beta-adrenergic agonists enhance lung liquid clearance in anesthetized adult sheep.
- The effect is mediated via beta receptors and likely involves active sodium transport across the alveolar epithelium.
More Related Videos
09:36Halogenated Agent Delivery in Porcine Model of Acute Respiratory Distress Syndrome via an Intensive Care Unit Type Device
Published on: September 24, 2020
07:02A Large Animal Model for Pulmonary Hypertension and Right Ventricular Failure: Left Pulmonary Artery Ligation and Progressive Main Pulmonary Artery Banding in Sheep
Published on: July 15, 2021
Related Concept Videos
Adrenergic Agonists: Direct-Acting Agents
These agents can be classified...
Adrenergic Agonists: Mixed-Action Agents
Ephedrine and pseudoephedrine lack a catecholamine group, making them less susceptible to degradation by metabolic enzymes. They have increased oral bioavailability and lipophilicity, resulting in a longer duration of action. Their response is reduced by...
Adrenergic Agonists: Therapeutic Classification
Vasopressor or pressor agents: They increase blood pressure and function as cardiac stimulants. Examples include endogenous catecholamines (norepinephrine and dopamine) and synthetic agents (phenylephrine).
Bronchodilators: β2-agonists can relax bronchial muscles and widen airways. They are commonly used for treating obstructive pulmonary...
Adrenergic Agonists: Therapeutic Uses
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and anaphylaxis:...
Adrenergic Antagonists: ɑ and β-Receptor Blockers
Antiasthma Drugs: β2-Adrenoceptor Agonists
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce relaxation in these...